Daniel Triggs
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions
Papers in
- Genetics 6
- Glioma Diagnosis and Treatment 6
- Virus-based gene therapy research 2
-
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 and COVID-19 Research 1
- Journals
- Science Translational Medicine (3 papers)Neuro-Oncology (2 papers)Nature (1 paper)The Journal of Infectious Diseases (1 paper)Communications Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Daniel Triggs
8 papers receiving 568 citations
Daniel Triggs's Hit Papers
Peers
Comparison fields: 5 of 46
- Genetics 262
- Genetics 187
- Oncology 100
- Immunology 74
- Biomaterials 19
Countries citing papers authored by Daniel Triggs
This map shows the geographic impact of Daniel Triggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Triggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Triggs more than expected).
Fields of papers citing papers by Daniel Triggs
This network shows the impact of papers produced by Daniel Triggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Triggs. The network helps show where Daniel Triggs may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 234 | |
| 2 | Clinical trial links oncolytic immunoactivation to survival in glioblastoma Hit paper breakdown → | 2023 | 214 |
| 3 | 2021 | 89 | |
| 4 | 2023 | 16 | |
| 5 | 2025 | 9 | |
| 6 | 2021 | 7 | |
| 7 | 2025 | 5 | |
| 8 | 2022 | 3 |
About Daniel Triggs
Daniel Triggs is a scholar working on Genetics, Infectious Diseases, Modeling and Simulation, Genetics and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 577 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Virus-based gene therapy research (2 papers), Telemedicine and Telehealth Implementation (1 paper), COVID-19 Clinical Research Studies (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), ECG Monitoring and Analysis (1 paper) and COVID-19 epidemiological studies (1 paper). The work is most often cited by research in Genetics (262 citations), Genetics (187 citations), Oncology (100 citations), Immunology (74 citations) and Biomaterials (19 citations). Daniel Triggs has collaborated with scholars based in United States. Their work appears in journals such as Science Translational Medicine, Neuro-Oncology, Nature, The Journal of Infectious Diseases and Communications Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.